Medis
Slavko Pušavec began their work experience in marketing at Iskra ERO in 1987, where they served as a Marketing Associate until 1990 and then became the Head of Marketing Communication until 1992. Slavko then moved on to a role as Marketing Manager at Dnevnik from 1992 to 1993. Pušavec next worked as a Marketing Coordinator at Interakcija d.o.o. & Finmedia d.d from 1993 to 1994. In 1994, they joined Medis (Medical Marketing Company) and served as a Marketing Assistant until 1997, followed by a position as Marketing Manager from 1998 to 2002. From 2003 until 2018, Pušavec took on the role of Assistant to the General Manager at Medis. Most recently, they have been serving as Chief Compliance Officer since April 2018.
Slavko Pušavec completed their high school education at Gimnazija Kranj from 1977 to 1981, obtaining a High School Diploma. Slavko then enrolled at the University of Ljubljana, Faculty of Economics from 1982 to 1986, where they earned a Bachelor of Science in Economics degree. In 1988, they obtained an IAA Certificate in Marketing Communications from the Faculty of Economics in Ljubljana and the Faculty of Social Sciences in Ljubljana. Later, in 2005, Slavko Pušavec received a Certificate in Advanced English (Council of Europe Level C1) from the University of Cambridge. Slavko also attended INSEAD in 2018, where they completed INSEAD Compliance Implementation Leadership I and II programs.
Medis
1 followers
For 34 years, we have been collaborating with global pharma and biotech partners to bring innovative therapies to patients in Central and Eastern Europe. Despite the region's challenging healthcare systems and complex yet promising markets, our team of 400 employees harnesses its expertise to ensure health equity in these underserved markets. Medis is a member of the World Orphan Drug Alliance (WODA) – a global alliance of full-service regional distributors for orphan and debilitating disease products. WODA covers 152 countries in the following regions: Central and Eastern Europe, Greater China, Israel, Greece, Malta, Cyprus, Latin America, the Middle East, North Africa & Turkey, Switzerland, Australia, New Zealand and South East Asia. Out-licensing: Become our commercialization partner and benefit from advanced, ready-to-launch consumer health products, which are already marketed in 20 countries and are further expanding. More information: www.medis.com/en/international-business/ Our business areas: • Therapeutics • Hospital Care • Consumer Health • Aesthetics Our value to partners: • Direct local presence in 18 CEE countries • Full commercialization • Single point of contact and delivery • Strategic and localized market access approach • Highest compliance standards • Financial and credit excellence Major Partners: • Therapeutics: Bial – Biogen – Besins – HRA Pharma – Mundipharma – Pierre Fabre – Santen – UCB • Hospital Care: Abbott – Aesculap – Asahi Medical – Biotest – B. Braun – Cytosorbents – Paion • Consumer Health: Pleuran – Ricerpharma – Karo Healthcare – Merz – Pohl Boskamp – UP – URGO • Aesthetics: Merz Aesthetics – Crown Aesthetics • Out-licensing partners: Ferrer – Pharmalink – Sarantis – Stada